Atossa Therapeutics Inc.

ATOS | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.29

+$0.04 (+1.78%)

Sep 22, 2026, 2:15 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	41.3M	71.08M	88.46M	110.89M	136.38M	39.66M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.71M	4.7M	n/a	n/a
Other Long-Term Assets	1.99M	1.99M	2.32M	635K	2K	17.22K
Receivables	n/a	n/a	n/a	743K	1.07M	634.94K
Inventory	n/a	n/a	1.49M	5.25M	n/a	n/a
Other Current Assets	243K	229K	977K	110K	1.3M	671.88K
Total Current Assets	45.62M	74.46M	92.22M	118.2M	141.24M	42.77M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	20K	38.69K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	13.38K
Total Long-Term Assets	1.99M	1.99M	4.03M	5.34M	22K	73.07K
Total Assets	47.61M	76.44M	96.25M	123.53M	141.26M	42.84M
Account Payables	4.29M	679K	806K	2.97M	1.72M	1.59M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	18.05K
Other Current Liabilities	1.99M	3.04M	1.8M	19K	1.1M	13.08M
Total Current Liabilities	8.26M	4.97M	5.24M	5.57M	3.13M	15.67M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	1K	1K	3.79K
Total Liabilities	8.26M	4.97M	5.24M	5.57M	3.13M	15.68M
Total Debt	n/a	n/a	n/a	n/a	n/a	18.05K
Book Value	39.35M	71.48M	91.02M	117.96M	138.14M	27.17M
Book Value Per Share	4.57	8.52	10.83	13.97	17.72	36.04
Common Stock	1.55M	23.49M	22.79M	22.79M	22.79M	8.56M
Retained Earnings	-246.56M	-211.79M	-186.29M	-156.19M	-129.23M	-111.9M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	39.35M	71.48M	91.02M	117.96M	138.14M	27.17M
Total Investments	n/a	n/a	1.71M	4.7M	n/a	n/a